hydantoins has been researched along with Kidney Failure, Chronic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ienaga, K; Mikami, H; Yokozawa, T | 1 |
| Ienaga, K; Yokozawa, T | 1 |
| Hasegawa, G; Ienaga, K; Nakano, K | 1 |
| Agnew, JR; Corey, AE; Parekh, NJ; Powell, JH; Thompson, GA; Valentine, SN | 1 |
| Brogard, JM; Coumaros, C; Schang, AM; Stahl, A | 1 |
5 other study(ies) available for hydantoins and Kidney Failure, Chronic
| Article | Year |
|---|---|
First indications demonstrating the preventive effects of NZ-419, a novel intrinsic antioxidant, on the initiation and/or progression of chronic renal failure in rats.
Topics: Animals; Antioxidants; Biomarkers; Creatinine; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Guanidines; Hydantoins; Kidney Failure, Chronic; Kidney Function Tests; Male; Methylguanidine; Oxidative Stress; Rats; Rats, Wistar; Succinates | 2009 |
Treatment with NZ-419 (5-Hydroxy-1-methylimidazoline-2,4-dione), a novel intrinsic antioxidant, against the progression of chronic kidney disease at stages 3 and 4 in rats.
Topics: Adenine; Administration, Oral; Animals; Antioxidants; Creatinine; Disease Models, Animal; Disease Progression; Glomerular Filtration Rate; Hydantoins; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Tubules; Male; Nephrectomy; Rats; Rats, Wistar | 2010 |
Serum accumulation of a creatinine oxidative metabolite (NZ-419: 5-hydroxy-1- methylhydatoin) as an intrinsic antioxidant in diabetic patients with or without chronic kidney disease.
Topics: Adult; Antioxidants; Creatinine; Diabetic Nephropathies; Female; Humans; Hydantoins; Kidney Failure, Chronic; Male; Middle Aged | 2011 |
Effect of severe renal impairment on the pharmacokinetics of azimilide following single dose oral administration.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Area Under Curve; Chromatography, High Pressure Liquid; Female; Humans; Hydantoins; Imidazoles; Imidazolidines; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Piperazines; Regression Analysis | 2002 |
[Technic of determination of serum allantoin and study of the action of uricase].
Topics: Allantoin; Humans; Hydantoins; Indicators and Reagents; Kidney Failure, Chronic; Methods; Urate Oxidase; Uric Acid | 1970 |